Abundance Wealth Counselors Lowers Stake in Kenvue Inc. $KVUE

Abundance Wealth Counselors lessened its stake in shares of Kenvue Inc. (NYSE:KVUE) by 31.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 62,944 shares of the company’s stock after selling 29,397 shares during the quarter. Abundance Wealth Counselors’ holdings in Kenvue were worth $1,086,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of KVUE. Salomon & Ludwin LLC purchased a new stake in shares of Kenvue during the third quarter worth approximately $25,000. NBT Bank N A NY raised its stake in shares of Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after buying an additional 1,006 shares in the last quarter. Cornerstone Planning Group LLC increased its holdings in Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after buying an additional 1,361 shares in the last quarter. Golden State Wealth Management LLC increased its holdings in Kenvue by 150.1% in the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after buying an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont increased its holdings in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after buying an additional 804 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on KVUE shares. Citigroup increased their target price on shares of Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a report on Wednesday, February 18th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a report on Wednesday, April 8th. Barclays dropped their target price on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday. Argus raised shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Finally, UBS Group dropped their target price on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a report on Tuesday, April 7th. Three equities research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $19.42.

Kenvue Stock Performance

NYSE:KVUE opened at $17.38 on Wednesday. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average price of $17.96 and a two-hundred day moving average price of $17.08. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17. The company has a market capitalization of $33.37 billion, a P/E ratio of 22.57, a price-to-earnings-growth ratio of 3.92 and a beta of 0.61.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.26 EPS. As a group, research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were given a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. Kenvue’s payout ratio is currently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.